JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGRE
3926
CALL
DELISTED
Paramount Group
PGRE
| $912K | ﹤0.01% |
200,000
| – | – |
|
3927
Southern First Bancshares
SFST
$608M
| $912K | ﹤0.01% |
29,692
-7,977
| -21% | -$314K |
|
3928
Lightwave Logic
LWLG
$1.17B
| $910K | ﹤0.01% |
174,112
+33,773
| +24% | +$188K |
|
|
QVCGA
3929
DELISTED
QVC Group Inc Series A
QVCGA
| $910K | ﹤0.01% |
18,429
+3,540
| +24% | +$318K |
|
|
DFS
3930
PUT
DELISTED
Discover Financial Services
DFS
| $909K | ﹤0.01% |
9,200
+7,800
| +557% | +$835K |
|
3931
iShares Core MSCI Pacific ETF
IPAC
$2.78B
| $906K | ﹤0.01% |
16,009
+9,161
| +134% | +$512K |
|
3932
Sinclair Inc
SBGI
$1.07B
| $904K | ﹤0.01% |
52,681
+9,898
| +23% | +$172K |
|
|
MPT
3933
CALL
Medical Properties Trust
MPT
$2.5B
| $904K | ﹤0.01% |
110,000
-3,100
| -3% | -$34.2K |
|
3934
CALL
Affirm
AFRM
$26.2B
| $902K | ﹤0.01% |
80,000
+40,000
| +100% | +$504K |
|
3935
Costamare
CMRE
$1.77B
| $901K | ﹤0.01% |
95,688
+40,408
| +73% | +$399K |
|
|
SCUA
3936
DELISTED
Sculptor Acquisition Corp I
SCUA
| $901K | ﹤0.01% |
86,300
| – | – |
|
3937
CALL
Target Hospitality
TH
$1.74B
| $900K | ﹤0.01% |
68,500
| – | – |
|
3938
CALL
Aflac
AFL
$60.9B
| $897K | ﹤0.01% |
13,900
| – | – |
|
3939
Innoviz Technologies
INVZ
$107M
| $892K | ﹤0.01% |
255,074
-14,455
| -5% | -$64.1K |
|
3940
Arbutus Biopharma
ABUS
$924M
| $891K | ﹤0.01% |
294,165
+221,321
| +304% | +$624K |
|
|
SP
3941
DELISTED
SP Plus Corporation
SP
| $890K | ﹤0.01% |
25,949
+5,204
| +25% | +$184K |
|
3942
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$42B
| $890K | ﹤0.01% |
19,733
+1,731
| +10% | +$74.2K |
|
3943
Yext
YEXT
$594M
| $889K | ﹤0.01% |
92,541
-132,336
| -59% | -$1.02M |
|
|
BZAI
3944
Blaize Holdings
BZAI
$85.9M
| $889K | ﹤0.01% |
87,437
| – | – |
|
3945
UNIFI
UFI
$120M
| $887K | ﹤0.01% |
108,613
+7,754
| +8% | +$69.1K |
|
3946
Allient
ALNT
$1.89B
| $886K | ﹤0.01% |
22,925
+14,008
| +157% | +$555K |
|
3947
iShares Morningstar Small-Cap Value ETF
ISCV
$712M
| $885K | ﹤0.01% |
16,956
-1,674
| -9% | -$91.9K |
|
3948
Cass Information Systems
CASS
$748M
| $882K | ﹤0.01% |
20,370
+2,670
| +15% | +$128K |
|
|
GRFS
3949
CALL
Grifois
GRFS
$5.29B
| $881K | ﹤0.01% |
+119,500
| New | +$1.04M |
|
|
GOLD
3950
Gold.com Inc
GOLD
$1.28B
| $875K | ﹤0.01% |
25,210
-981
| -4% | -$32.6K |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.